IRIS
GENTILE, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.255
NA - Nord America 3.351
AS - Asia 2.381
SA - Sud America 653
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.712
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.244
RU - Federazione Russa 2.108
SG - Singapore 1.032
CN - Cina 603
BR - Brasile 544
IT - Italia 537
IE - Irlanda 486
HK - Hong Kong 298
SE - Svezia 283
DE - Germania 203
FR - Francia 144
PL - Polonia 142
FI - Finlandia 138
VN - Vietnam 132
IN - India 99
GB - Regno Unito 77
BD - Bangladesh 57
CA - Canada 50
AR - Argentina 44
MX - Messico 34
AT - Austria 26
NL - Olanda 26
TR - Turchia 26
ID - Indonesia 23
EC - Ecuador 21
JP - Giappone 20
BE - Belgio 19
MA - Marocco 16
ZA - Sudafrica 16
UA - Ucraina 15
PK - Pakistan 13
UZ - Uzbekistan 12
VE - Venezuela 12
CI - Costa d'Avorio 10
ES - Italia 10
IQ - Iraq 9
CO - Colombia 8
LT - Lituania 8
TN - Tunisia 8
AZ - Azerbaigian 7
KE - Kenya 7
MY - Malesia 7
PE - Perù 7
CL - Cile 6
CZ - Repubblica Ceca 6
NP - Nepal 6
PH - Filippine 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
PY - Paraguay 5
SA - Arabia Saudita 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
EU - Europa 3
HN - Honduras 3
JM - Giamaica 3
LK - Sri Lanka 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AL - Albania 2
BH - Bahrain 2
CH - Svizzera 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
UG - Uganda 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
DK - Danimarca 1
EG - Egitto 1
GN - Guinea 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MN - Mongolia 1
PA - Panama 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 10.712
Salva come PNG Salva come JPEG
Città #
Ashburn 774
Moscow 673
Singapore 545
Dublin 482
Dallas 381
Chandler 320
Hong Kong 294
Nyköping 214
San Jose 207
Beijing 200
Messina 193
Warsaw 138
Munich 133
The Dalles 111
Los Angeles 78
Lauterbourg 75
Princeton 72
Helsinki 70
Medford 63
Ann Arbor 50
Des Moines 49
Buffalo 42
Council Bluffs 40
New York 40
Ho Chi Minh City 39
Jacksonville 37
São Paulo 36
Tianjin 35
Pune 30
Turku 30
Wilmington 29
Santa Clara 27
Bremen 24
Dearborn 24
Orem 23
Redondo Beach 22
Lappeenranta 21
Palermo 21
Chennai 20
Hyderabad 20
Seattle 20
Cambridge 19
Guangzhou 19
London 19
Belo Horizonte 18
Hanoi 18
Nuremberg 18
Rome 18
Chicago 17
Rio de Janeiro 17
Jinan 16
Tokyo 16
Boardman 15
Brooklyn 15
Brussels 15
Frankfurt am Main 15
Milan 15
Redwood City 14
Houston 13
San Francisco 13
Shanghai 13
Vienna 13
Boston 12
Brasília 12
Curitiba 12
Duncan 12
Falls Church 12
Tashkent 12
Amsterdam 11
Mexico City 11
Montreal 11
Abidjan 10
Catania 10
Guayaquil 10
Jakarta 10
Porto Alegre 10
Toronto 10
Zhengzhou 10
Denver 9
Poplar 9
Campinas 8
Changsha 8
Dong Ket 8
Johannesburg 8
Ningbo 8
Shenyang 8
Shenzhen 8
Atlanta 7
Baku 7
Da Nang 7
Istanbul 7
Livorno 7
Manaus 7
Nanjing 7
Phoenix 7
San Mateo 7
Taizhou 7
Woodbridge 7
Ankara 6
Baghdad 6
Totale 6.376
Salva come PNG Salva come JPEG
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 366
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 329
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 253
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 248
A Nouvel serum MicroRNA signature to screen ATTR 228
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 216
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 212
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 198
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 193
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 189
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 174
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 172
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 170
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 168
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 168
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 167
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 163
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 156
Predicting needlestick and sharps injuries in nursing students: Development of the SNNIP scale 153
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 153
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 152
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 148
Clinical and genotype characteristics and symptom migration in patients with mixed phenotype transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey 142
A multicentre study on epidemiology and prevention of needle stick injuries among students of nursing schools 129
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 129
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 129
A Cyst Compressing the Ulnar Nerve Motor Branch: Ultrasonographic Diagnosis of a Tricking Neuropathy. 128
Considerable post-partum worsening in a patient with CMT2E 126
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 126
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 125
"It is not what it seems." Ultrasound findings in a case of unusual iatrogenic ulnar nerve damage. 120
Use of the International Classification of Functioning, Disability and Health Generic-30 Set for the characterization of outpatients: Italian Society of physical and rehabilitative medicine residents section project 119
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 117
A multicentric study of the disease risks and first manifestations in Hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis 116
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 115
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma 114
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 114
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 114
"Seeing Through the Wall": Ultrasound Application for the Diagnosis and Treatment of Abdominal Pain. 114
"Who seeks finds, who compares discovers". Usefulness of ultrasound to assess small nerve branches. 114
Unilateral hyperhidrosis as persistently isolated feature of syringomyelia and Arnold Chiari type 1 113
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 113
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 106
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 106
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 105
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers 105
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 103
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 103
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS) 102
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 102
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 99
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: data from the Italian CIDP database 99
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 96
Early detection of cardiac amyloid deposition in subjects with transthyretin gene mutation by 99mTc-disphosphonate scintigraphy 96
The THAOS: record of patients from our site. 95
Impact of environmental factors and physical activity on disability and quality of life in CIDP 94
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 92
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 91
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 91
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation 90
Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis 90
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 89
Early detection of cardiac amyloid deposition in patients with transthyretin-related familial amyloid polyneuropathy by 99mTc-diphosphonate scintigraphy 88
Phenotypic spectrum of myelin protein zero-related neuropathies: a large cohort study from five mutation clusters across Italy 87
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 87
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 86
TRPA1 rare variants in chronic neuropathic and nociplastic pain patients 85
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the transthyretin amyloidosis outcomes survey (THAOS) 85
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years 84
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 84
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 80
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update 79
Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy 79
(TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 78
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy 77
Use of drugs for ATTRv amyloidosis in the real world: How therapy is changing survival in a non-endemic area 77
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 76
Comparison of the diagnostic accuracy of the 2010 European Federation of Neurological Societies/Peripheral Nerve Society and American Association of Electrodiagnostic Medicine diagnostic criteria for multifocal motor neuropathy 76
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: data from an early-access program in Italy 75
Ultrasound guidance increases diagnostic yield of needle EMG in plegic muscle. 69
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 68
Rare among rare: Phenotypes of uncommon CMT genotypes 67
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 66
Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area 64
Shear wave elastography of median nerve at wrist and forearm. Heterogeneity of normative values. 60
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS 55
null 54
Frequency, entity and determinants of fatigue in Charcot-Marie-Tooth disease 43
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran 38
Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy 36
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 31
null 30
Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth disease 29
Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? 28
Daytime sleepiness and sleep quality in Charcot-Marie-Tooth disease 26
Machine Learning for Early Diagnosis of ATTRv Amyloidosis in Non-Endemic Areas: A Multicenter Study from Italy 25
Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation 23
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational study 22
null 22
Phenotype-Genotype Correlations in Early-Onset Myelin Protein Zero–Related Neuropathies 20
Totale 11.006
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.555
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 0 0 16
2021/2022468 14 47 3 16 39 11 47 28 16 22 31 194
2022/20231.267 105 115 77 76 86 114 18 61 562 13 25 15
2023/2024392 27 54 21 27 32 107 16 32 5 25 6 40
2024/20252.205 72 22 48 141 137 141 202 312 441 124 212 353
2025/20265.774 321 462 434 357 478 1.147 682 699 642 299 129 124
Totale 11.041